Neurology: Neuroimmunology & NeuroInflammation is an official journal of the American Academy of Neurology.
Vision: Neurology: Neuroimmunology & Neuroinflammation will be the premier peer-reviewed journal in the fields of neuroimmunology and neuroinflammation.
Mission: Neurology: Neuroimmunology & Neuroinflammation will provide neurologists and clinical research scientists with outstanding peer-reviewed articles, editorials, and reviews to enhance patient care and facilitate basic and translational research.
Neurology: Neuroimmunology & NeuroInflammation publishes rigorously peer-reviewed open access reports of original research and in-depth reviews of topics in neuroimmunology & neuroinflammation, affecting the full range of neurologic diseases including (but not limited to): Alzheimer disease, Parkinson disease, ALS, tauopathy, and stroke; multiple sclerosis and NMO; inflammatory peripheral nerve and muscle disease, Guillain-Barré and myasthenia gravis; nervous system infection; paraneoplastic syndromes, noninfectious encephalitides and other antibody-mediated disorders; and psychiatric and neurodevelopmental disorders. Clinical trials, instructive case reports, and small case series will also be featured.
The 2019 Impact Factor for Neurology: Neuroimmunology & Neuroinflammation is 7.724 (2019 Journal Citation Reports® [Clarivate Analytics, 2020]).
Neurology: Neuroimmunology & Neuroinflammation is indexed in MEDLINE/PubMed, PMC, Scopus, EMBASE, Google Scholar, DOAJ, CrossRef, Science Citation Index Expanded (SCIE), and Current Contents®/Clinical Medicine.
